Errors of commission or omission: The net risk safety analysis conversation we should be having around automated insulin delivery systems

Abstract

The question of safety often arises when discussing automated insulin delivery systems, but discussion of safety is often anchored on a comparison to the risk to a person without diabetes, overlooking the risks of living with insulin-requiring diabetes. We should use a net risk safety perspective for evaluating diabetes technology that takes into account the ongoing risks of insulin management for people living with diabetes.

Keywords: AID; APS; artificial pancreas; automated insulin delivery; closed loop; hybrid closed loop; risk analysis.